Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Royal Academy of Engineering has awarded seven fellowships to engineering researchers whose projects have the potential to bring radical innovation to their fields. Dr Tom Okell is the recipient of one of the fellowships. He will benefit from financial support and mentoring for five years for his research into novel imaging techniques to visualise blood flow in the brain.

Non-invasive imaging techniques that show the blood flow to the brain are valuable tools, enabling doctors to make accurate diagnoses and plan interventions. Ideally, to reduce risks to the patient to an absolute minimum, these imaging techniques should use the least possible amount of ionising radiation or contrast agents.

Arterial spin labelling is a type of magnetic resonance imaging that fulfils these requirements and can be used to produce detailed maps of the brain tissues infused by blood (perfusion), and also to perform angiography, which shows the flow of blood within arteries.

Current methods that use this technique for detailed angiography are time-consuming and perfusion information must be obtained in a separate scan. With constraints on clinical scan times it is often not possible to perform both perfusion imaging and angiography in the same session, leaving the specialist with incomplete information.

Dr Okell is working to resolve this issue and to allow both measurements to be performed simultaneously. Treating angiography and perfusion not as separate techniques but as different windows on a continuous process, Dr Okell will develop the way the measurements are performed and recorded to simultaneously produce detailed results for both perfusion and angiography in a fraction of the time normally required. 

Read more...

Similar stories

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

COVID-19 infection has greater risk than vaccines of causing very rare neurological events

Research reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.